Product Detail

loading

Share to:
facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
whatsapp sharing button
sharethis sharing button

Cas No. 886061-26-3, Capivasertib intermediate

  • 886061-26-3

  • C9H12ClNO

  • 185.65

  • 1.216

  • 98% min (HPLC)

  • 152.1

  • Off-white powder

  • Breast Cancer

  • Capivasertib

  • Serine/Threonine Kinase

  • N

  • ISO 9001;ISO 14001;ISO 45001

  • CDMO

Availability:
Cas No. 886061-26-3, Capivasertib intermediate

Product Description

(3S)-3-amino-3-(4-chlorophenyl)propan-1-ol, Cas No. 886061-26-3, is the chiral molecule. It is a key Capivasertib intermediate.


Capivasertib key intermediates



References

Tse, M. K. et al. Ruthenium‐Catalyzed Asymmetric Epoxidation of Olefins Using H 2 O 2 , Part I: Synthesis of New Chiral N , N , N ‐Tridentate Pybox and Pyboxazine Ligands and Their Ruthenium Complexes. Chemistry A European J 12, 1855–1874 (2006).
 


Woodhead, S. J. et al. Substituted Piperidines Containing a Heteroarylamide or Heteroarylphenyl Moiety. (2008).

 


Johnson, P. D., Leach, A., Luke, R. W. A., Matusiak, Z. S. & Morris, J. J. Pyrrolo [2, 3 -D] Pyrimidin Derivatives as Protein Kinase B Inhibitors. (2009).

 


Addie, M. et al. Discovery of 4-Amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an Orally Bioavailable, Potent Inhibitor of Akt Kinases. J. Med. Chem. 56, 2059–2073 (2013).


Lan, R. et al. Aminopyrimidine derivatives for use as modulators of kinase activity. (2013).


Aavula, S. K., Chandukudlu, H. V. K., Chikkulapalli, A. & Chinnakalai, K. Processes for the Preparation of Azd5363 and Novel Intermediate Used Therein. (2015).


Matsunaga, H., Sugihara, T. & Yamada, K. 2,6-Dichloro-8-Iodo-7-Deazapurine for Synthesizing Polysubstituted 7-Deazapurine Derivative. (2016).


Zhou, W. et al. Substrate-controlled Diastereoselective Michael Addition of Alkylidene Malonates by Grignard Reagents. Heterocyclic Communications 25, 116–121 (2019).


Blaquiere, N. A. et al. Compounds and Compositions for the Treatment of Parasitic Diseases. (2021).


Huang, L., Dong, Y., Xu, D., Yue, L. & Li, J. Preparation method of initial amino acid Boc-Pip (Fmoc)-OH. (2023).


Previous: 
Next: